These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12767494)

  • 1. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies.
    Katsuse O; Iseki E; Marui W; Kosaka K
    J Neurol Sci; 2003 Jul; 211(1-2):29-35. PubMed ID: 12767494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of human alpha-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Sawada H; Uéda K; Kosaka K
    Neurosci Lett; 2000 Aug; 290(1):41-4. PubMed ID: 10925170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
    Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.
    Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
    Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions.
    Iseki E; Takayama N; Furukawa Y; Marui W; Nakai T; Miura S; Uéda K; Kosaka K
    Neurosci Lett; 2002 Jul; 326(3):211-5. PubMed ID: 12095658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains.
    Iseki E; Takayama N; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(1):85-91. PubMed ID: 11867079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies.
    Togo T; Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
    J Neurol Sci; 2001 Feb; 184(1):71-5. PubMed ID: 11231035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical Lewy body disease.
    Burn DJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):175-8. PubMed ID: 14742580
    [No Abstract]   [Full Text] [Related]  

  • 12. Lewy body-related alpha-synucleinopathy in aging.
    Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
    Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
    Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
    Gómez-Tortosa E; Newell K; Irizarry MC; Sanders JL; Hyman BT
    Acta Neuropathol; 2000 Apr; 99(4):352-7. PubMed ID: 10787032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
    Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
    Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.